An accurate, simple, sensitive and selective micellar liquid chromatographic method has been developed for the simultaneous determination of caffeine (CAF) and two non-steroidal anti-inflammatory drugs, namely ibuprofen (IBU) and ketoprofen (KET). The chemometric approach was applied to the optimization of separation of the studied drugs. To optimize their separation, the effect of six experimental parameters on retention was investigated by means of multivariate analysis. Separation was conducted using an ODS C18 (150 3 4.6 mm i.d.) stainless steel column at ambient temperature with UV detection at 260 nm. A mobile phase composed of 40 mM sodium dodecyl sulphate (SDS), 10% 1-propanol and 0.3% tri-ethylamine in 0.02 M phosphoric acid adjusted to pH 3 has been used at a flow rate of 1 mL/min. Regression models were characterized by both descriptive and predictive ability (R 2 ! 97.9% and R cv 2 ! 96.2%) and allowed the chromatographic separation of the drugs with a good resolution and a total analysis time within 15 min. The calibration curves were rectilinear over the concentration ranges of 2.0-25.0, 1.5-15.0 and 1.0-10.0 mg/mL for IBU, KET and CAF, respectively, with detection limits of 1.2, 1.0 and 0.6 mg/mL, and quantification limits of 1.6, 1.2 and 0.8 mg/mL, respectively. The results obtained were in good agreement with those obtained by the comparison method.
Introduction
Micellar liquid chromatography (MLC) has been recently developed as a useful chromatographic method due to its ability to separate ionic and nonionic compounds and the possibility of direct injection of biological fluids such as serum and plasma. Other advantages include the enhancing effect of micelle formation on luminescence intensity, low cost, low volatility of mobilephase constituents and much less amount of toxic organic solvents (environmentally benign) (1) .
The optimization of the experimental conditions is a complicated process in MLC due to the large number of the variables, which must be simultaneously treated. These variables include pH of the mobile phases, concentration of surfactant, type, and volume fraction of organic modifier, flow rate and column type. Variations of the experimental conditions affect both the retention of the analytes and the extent of the surfactant monomers adsorbed onto the stationary phase. As a result, the effect of these factors on retention can be interdependent and nonlinear (2 -4) . Therefore, methods of multivariate analysis are usually used.
In order to optimize the time of the chromatographic analysis and the resolution, chemometric methods of experimental design, multivariate analysis and multi-criteria decision making (Pareto-optimality) (5) were employed. The six experimental variables considered were: SDS concentration; the organic modifier concentration, Cm; the alkyl chain length of organic modifier, N; pH of the mobile phase, flow rate Fl and type of column. The experiments for the optimization were performed according to the face-centered cube response surface experimental design. Subsequently, the method of stepwise multiple linear regression was used to select the most important effects and to calculate the coefficients relating the effects to retention time. The Paretooptimal approach was used for the evaluation of the optimal points.
Non-steroidal anti-inflammatory drugs (NSAIDs) are widely used as analgesics and at higher doses, as anti-inflammatory in the treatment of rheumatic diseases and other musculoskeletal disorders. Besides these actions, NSAIDs act as middling central nervous system (CNS) depressors. Thus, for preventing this soft CNS depression, central stimulants (i.e., caffeine, CAF) are added sometimes to dosage forms (6, 7) . They are introduced all over the world in many pharmaceutical formulations either alone or with adjuvant drugs whether to synergize or to impart added effect. Thus, an urgent need arises for the development of analytical methods for their determination in their pharmaceutical mixtures. Two NSAIDs, namely ibuprofen (IBU) and ketoprofen (KET), were selected for our analytical study.
A good survey of the work published of the three drugs respectively is found in the comprehensive monographs in their analytical profiles (8 -10) .
Mbinze et al. (11) optimized the separation conditions for 27 molecules among which were 18 NSAIDs. To achieve this objective, design of experiments (DoE) was utilized to establish a design space (12) , based on a predictive statistical model of the retention times. DoE with predictive probability simultaneously optimize the separation and estimate the method robustness over the experimental domain.
A reverse-phase-high-performance liquid chromatography (HPLC) method for simultaneous determination of CAF, paracetamol and p-aminophenol (13), using full factorial design, for a total of eight experiments was performed, where the number of experiments corresponds to all possible combinations of selected factors, and levels, meaning that for large number of factors, for example, 8, at two levels, 256 experiments are required. Full factorial design is most useful when the number of factors is relatively limited. This experiment was covered with three variables which were considered to be possibly influencing the outcome.
Literature survey revealed one report for the simultaneous determination of the studied NSAIDs with CAF (14) applying a tedious and complicated gradient elution method, where a two solvent gradient elution was performed, solvent A being an aqueous formic acid: formate buffer (0.1 M) of pH 3, and solvent B methanol. The starting mobile phase was 90% A and 10% B, and the linear gradient was run over 10 min to a proportion of 45% A and 55% B, and then continued to a final proportion of 100% B at 30 min. Relatively expensive solvents and low sensitivity parameters-(10-35, 5-35, 60-120 mg/mL) linearity ranges of CAF, KET and IBU, respectively, with corresponding limits of detection (LODs) of 1.7, 0.9 and 4.3 mg/mL, and limits of quantification (LOQs) of 5.7, 3.1 and 14.2 mg/mL-were encountered, which gives this work a remarkable advantage regarding economic and sensitivity parameters.
Therefore, the present study aimed at developing and validating a simple, selective and accurate new MLC method for the simultaneous determination of IBU or KET with CAF. 
Experimental

Instrumentation
MLC method
Separation was achieved on an EC nucleosil C18-SN: 4115568 column (150 Â 4.6 mm i.d., 5 mm) combined with a guard column (Merck, Darmstadt, Germany). The columns were operated at ambient temperature. The analytical system was washed daily with 60 mL of a 1:1 mixture of water and methanol to eliminate the mobile phase; this did not cause any change in the column performance. The mobile phase was prepared by mixing 40 mM SDS, 10% 1-propanol and 0.3% tri-ethylamine in 0.02 M phosphoric acid, and adjusting the pH to 3. The mixture was then sonicated for 30 min. The resulting mobile phase was filtered through a 0.45-mm membrane filter (Millipore, Ireland).
Standard solutions and calibration
A stock solution containing 1.0 mg/mL of IBU, KET, or CAF was dissolved in 10 mL methanol and further diluted with the mobile phase to obtain a final concentration of 100.0 mg/mL. These solutions were found to be stable for at least 2 weeks when kept in the refrigerator. A stock solution containing 1.0 mg/mL of EBS internal standard was prepared in methanol and further diluted with the mobile phase to obtain a final concentration of 100.0 mg/mL.
Calibration of MLC method
Aliquots of IBU, KET and CAF standard solutions covering the working concentration ranges of 2.0 -25.0, 1.5 -15.0 and 1.0 -10.0 mg/mL, respectively, were transferred into a series of 10 mL volumetric flasks, mixed with 1 mL aliquots of EBS internal standard (final concentration 10.0 mg/mL) and diluted with the mobile phase to the mark. Twenty microliters of aliquots were injected (in triplicates) and eluted with the mobile phase under the described chromatographic conditions. The calibration curves were constructed by plotting the peak area ratios against the final concentrations of the drugs (mg/mL). Alternatively, the corresponding regression equations were derived.
Analysis of laboratory-prepared mixture Aliquots of IBU/CAF and KET/CAF standard solutions in ratios of 4:1 and 1:1 were transferred into a series of 10 mL volumetric flasks, mixed with 10.0 mg/mL of EBS (International Standard), and diluted with the mobile phase to the mark. Then, the steps described under "Calibration of MLC method" were preceded. The percentage recoveries were calculated by referring to the calibration graphs previously prepared or by applying the regression equations.
Analysis of laboratory-prepared co-formulated tablets
Laboratory-prepared tablets containing 200 mg IBU and 50 mg CAF or 50 mg KET and 50 mg CAF were prepared by mixing the drugs with the tablet excipients: lactose (15 mg), starch (15 mg), talc (20 mg) and magnesium stearate (10 mg) per each tablet. An accurately weighed quantity of the mixed contents of 10 prepared tablets equivalent to 4.0 mg IBU and 1.0 mg CAF or 1.0 mg KET and 1.0 mg CAF (according to their pharmaceutical ratio) was transferred into a small conical flask and extracted with 3Â 30 mL of methanol. The extract was filtered into a 100-mL volumetric flask. The conical flask was washed with few milliliters of methanol; the wash was added to the filtrate and completed to the mark with the same solvent. The procedure was followed as described under "Calibration of MLC method". The nominal contents of the laboratory-preparedtablets were calculated using either the calibration graphs or the corresponding regression equations.
Results
The proposed liquid chromatographic method permits the separation and quantitation of IBU, KET and CAF in their mixture. Under the described chromatographic conditions, clear base line separation with satisfactory resolution between the peaks was achieved in a short chromatographic run: 15 min. The proposed method was assessed for selectivity, linearity, precision, accuracy, stability and recovery.
The different experimental parameters affecting the separation selectivity of the liquid chromatographic system have been investigated and optimized. Hence, the method was applied to the determination of the studied drugs in their laboratoryprepared combined tablets.
Discussion
For decades, HPLC separations were based on a trial-and-error methodology. The traditional approach entails studying the influence of the corresponding factors by changing one single (or separate) factor at a time (COST) while keeping the others constant (15) . The technique, at times, is also known as OFAT (one factor at a time) (15) (16) (17) . Many years of experience has shown that these COST methods are inefficient and time consuming as they require a great amount of effort ( planned experiments) and time without actually (in many cases) being able to identify the optimum conditions (15, 18) . These drawbacks forced scientists to consider more efficient systematic optimization techniques involving aspects such as experimental design. The principles behind these techniques (known as DoE) encompass the use of experimental design, generation of mathematical equations and graphic outcomes (15) .
Employing various rational combinations of factors, statistical experimental design fits experimental data into mathematical equations (known as models) in order to predict and optimize the examined responses. Examples of HPLC development and optimization attempts with the aid of DoE have shown important advantages (19) (20) (21) (22) .
The present paper succeeded in developing and optimizing a MLC method for the simultaneous determination of CAF with some NSAIDs using experimental design. The significance of the studied factors was evaluated with the aid of a fractional factorial design while the optimum chromatographic conditions were estimated by a central composite design using both a graphical (overlay contour plots) and a mathematical global optimization approach.
The approach of multivariate optimization Before starting an optimization procedure, it is important to identify the crucial factors affecting the quality of the derived outcomes. In the present study, the significance of six independent factors on the quality of the separation was investigated using a two-level fractional factorial design. The selection of factors for optimization was based on preliminary experiments and prior knowledge from literature, as well as certain instrumental limitations. The six factors selected in this work were considered to be possibly influencing the outcome. Screening designs can identify significant main effects rather than interaction effects. Therefore, these are usually first-order designs with low resolution (15) . Two-level factorial designs (2 k ) are the simplest form of orthogonal design employed for screening k number of factors (23) . The mathematical model associated with design consists of main and ( possible) interaction effects as presented in the following equation (24):
where n is the number of factors, X is the factor examined, Y is the measured response and b 0 , b i , b ij represent the coefficients for each main or interaction effect. In the present study, six factors (Table I) were examined in two levels: (1) pH of the mobile phase (X1), (2) the alkyl chain length of organic modifier (X2), (3) SDS concentration (X3), (4) the organic modifier concentration (X4), (5) flow rate (X5) and (6) type of column (X6). The high and low levels of factors were determined based on preliminary experiments. All experiments were conducted in randomized order and in triplicate.
Factorial design
The experiments used for modeling and optimization of the studied drugs were performed on three levels for each of the six factors. Face-centered cube response surface experimental design was used. This design is one of the experimental designs suitable for modeling and optimization. The feasible region of the selected chromatographic factors in which the experimental optimization could be carried out is listed in Table I . A full factorial design for six variables and two levels would require 64 experiments. To reduce the number of experiments, a two-level fractional experimental design consisting of 2 623 experiments was used. This reduced design allows the first estimation of the principal factor effects confounded with the second-order interaction; however, this leads to a partial loss of information. Experiments 3-10 in Table I show fractional factorial design. The experiment in the central point (experiments 1, 2, 11, 12, 21, and 34) was replicated to estimate the pure experimental error and to check system reproducibility. The analysis of these results showed that the retention of all the analytes is largely affected by the pH of the mobile phase and SDS concentration. A comparison between the experimental and predicted separation parameters is shown in Table II .
Fold-over fractional factorial design
For better understanding of the typical factors that govern the retention, a complementary set of experiments as fold-over design was performed (Table I , experiments 13 -20) . This represents a fold-over of the previous design and is obtained by changing the sign of the three last columns of the fractional design. Fold-over design is used to separate the principal effects from the confounded second-order interactions. The combined results (fold-over and fractional factorial design) confirmed the previously observed results. For all the analytes, the largest effects on retention time (t R ) were due to pH and SDS concentration. Slight effect was observed due to the other main factors.
Star design
The existence of quadratic (or higher) significant effects was tested by means of F-test that compares the difference between the experimental retention time in the central point and factorial design (25) . The equation for F-test is according to the following equation: pe is the purely experimental variance. Since for all the compounds, the calculated F-values were greater than the critical F-value, it was concluded that the quadratic (or higher) effects must be used in the regression models. For this purpose, 13 experiments of a star design (experiments 22 -33 in Table I) were added to the factorial experimental design to provide a composite design. The best regression models were obtained by a variable selection algorithm. The final models showed R 2 cv ! 96:2% and R 2 ! 97.9% clarifying the fitting of these models and their satisfactory prediction ability. In order to optimize the separation of the studied drugs, a grid search program was applied. In this program, the predicted retention times of all analytes are available for every mobile-phase composition within the feasible factor space.
After a detailed investigation, separation of the studied drugs was achieved using a mobile phase consisting of 40 mM SDS, 10% 1-propanol and 0.3% tri-ethylamine in 0.02 M phosphoric acid, adjusted to pH 3.
Optimization of design and analysis
Statistical analysis tools (analysis of variance (ANOVA)) were used in order to identify significant effects. The response factors chosen were: (1) the retention time of the first eluted peak RtCAF (caffeine), since it may overlap with solvent front, (2) the retention time of the last peak RtIBU (ibuprofen) due to importance of total chromatographic run and (3) the chromatographic optimization function (COF).
COF is calculated according to the equation (24):
where A i and B are weighted parameters (equal to unity in this study), Rs i is the resolution of the ith pair, Rs id is the desired resolution for the specific pair (equals to 1.5), t M represents the desired maximum analysis time (here assumed 20 min) and t L is the actual time of the last eluted peak. COF was used in the present study because it has the ability to reduce data from each chromatogram to a single number which can be used in the optimization procedure. A good peak resolution and small elution time (desirable outcome) result in a greater COF value. It is crucial to remember that COF works satisfactorily only when all peaks have the same relative order of retention in all conditions (24) . Response transformations were made when necessary. The statistical analysis (ANOVA) is given in Table III . An independent factor had significant effect on a given response when it had a P-value , 0.05. The results indicated that only pH and SDS concentration had significant effect on the selected responses. Two-level interactions between the examined factors (X1X3) also showed significant effects (Table III) . R 2 adj was greater than 0.999 in all cases, revealing good fit of the experimental data.
Optimization using central composite design Central composite design can be applied to the optimization of an HPLC separation by gaining a better understanding of the factor's main and interaction effects (21) . The key factors Rs is the resolution factor:
NTP is the number of theoretical plates:
. HETP is the height equivalent to a theoretical plate: HETP ¼ L/N (t R is the retention time, t M is the time from injection to the appearance of the solvent front, w 1/2 is the peak width at half height, L is the length of the column and w R and w M are the peak width at base line for the drug and the solvent front, respectively). examined in the optimization phase (selected previously from the screening stage) were: pH of the mobile phase (A) and concentration of SDS (B).The retention time of caffeine RtCAF, the retention time of ibuprofen RtIBU and the COF were selected as responses. All experiments were conducted in a randomized order. Table IV summarizes the conducted experiments and  responses. Statistical parameters obtained from ANOVA are given in Table III . The insignificant terms were eliminated from the model through backward elimination process. From Table III it was concluded that pH (factor A) had the most important effect on RtIBU while [SDS] (factor B) mostly affected RtCAF. Factor interactions (AB) also had a significant effect on the measured responses. The derived regression models are also shown in Table III .
In order to gain a better understanding of the results, the predicted models are presented in Figure 1 as the perturbation plot. For an optimization design, this graph shows how the response changes as each factor moves from a chosen reference point, with all other factors held constant at the reference value (21). A steep slope or curvature in a factor indicates that the response is sensitive to that factor.
Method validation
Linearity and range Under the above-described experimental conditions, a linear relationship was established by plotting peak area ratios for the studied drugs to the internal standard against drugs concentrations in mg/mL. The concentration ranges were found to be 2.0 -25.0, 1.5 -15.0 and 1.0 -10.0 mg/mL for IBU, KET or CAF, respectively. The high value of the correlation coefficients (r . 0.999) with a small value of intercept indicate the good linearity of the calibration graphs over the working concentration ranges. Statistical analysis of the data gave small values of the standard deviation of the residuals (S y/x ), of slope (S b ) and of intercept (S a ) (Table V) (26) , thus indicating low scattering of the points around the calibration curve.
LOQ and LOD
The LOD is the lowest concentration of the drug that can be detected, but not necessarily quantitated, under the stated experimental conditions. The limit of detection is generally quoted as the concentration yielding a signal-to-noise ratio of 3:1 (27) and is confirmed by analyzing a number of samples near this value using the following equation:
The signal-to-noise ratio s ¼ H h
where H , height of the peak corresponding to the drug; h , absolute value of the largest noise fluctuation from the baseline of the peak of a blank solution.
The LOQ is the lowest concentration of the analyte that can be determined with acceptable precision and accuracy. It is quoted as the concentration yielding a signal-to-noise ratio of 10:1 and is confirmed by analyzing a number of samples near this value (27) .The calculated values are listed in Table V .
Accuracy
The accuracy of an analytical method is defined as the similarity of the results obtained by this method to the true values. To test 
the validity of the method, it was applied to the determination of pure samples of the drugs concerned over the working concentration ranges. The high percentages recoveries and small values of SD indicate the accuracy of the proposed method. The accuracy of the proposed MLC method was also evaluated by studying the accuracy as percent relative error (%Error) and precision as percent relative standard deviation (%RSD), and the results are shown in Table VI . The proposed method was also applied to the simultaneous determination of the studied drugs in their laboratory-prepared mixtures (Table VI) containing different concentrations of IBU/CAF and KET/CAF standard solutions in ratios of 4:1 and 1:1, respectively, as present in their co-formulated tablets. The concentrations of the drugs in the synthetic mixtures were calculated according to the linear regression equations of the calibration graphs. The results obtained were compared with those obtained using the comparison method (14) .
Precision
The intraday precision was evaluated through replicate analysis of three different concentrations of the drugs in pure form on three successive times. The interday precision was also evaluated 
Specificity
The specificity of the proposed MLC method was proved by its ability to determine the drugs in their laboratory-prepared tablets confirming that there was no interference by common excipients and additives such as lactose, starch, talc and magnesium stearate.
The placebo consisting of all these excipients-omitting the active ingredient-was injected under the described chromatographic conditions for the assay.
Solution stability and mobile-phase stability The stability of the stock solutions was determined by quantitation of the drugs and comparison with freshly prepared standard solutions. No significant change was observed in standard solution response relative to freshly prepared standards. Similarly, the stability of the mobile phase was checked. The results obtained in both cases proved that the sample solutions and mobile phase used during the assay were stable up to 14 and 30 days, respectively.
Applications
Analysis of CAF/IBU and CAF/KET in mixtures and laboratory-prepared co-formulated tablets The proposed method was applied to the simultaneous determination of CAF/IBU and CAF/KET in synthetic mixtures that are medicinally recommended in ratios of 1:4 and 1:1 (w/w), respectively, as the case in tablets (Figure 2 , Table VI ). Furthermore, the proposed method was successfully applied to the determination of the studied drugs in their laboratory-prepared co-formulated tablets. The results shown in Table VI are in good agreement with those obtained using the comparison HPLC method (14) . These matrix components did not show any interfering peaks at the retention times of the drugs. The high percentage recoveries and the small values of the relative standard deviations and percentage relative errors indicate the high accuracy and precision of the proposed method, respectively.
Co-administered drugs
The proposed method allows the determination of the studied drugs in the presence of some co-administered drugs such as Figure 2 . None of the above-mentioned drugs interfered with the MLC assay of the studied drugs.
Conclusion
A simple, sensitive and selective MLC method has been developed for the simultaneous determination of IBU, KET and CAF in their laboratory-prepared mixtures and co-formulated tablets. The results obtained were in good agreement with those obtained by the comparison method. The simplicity and low cost of the proposed method allows its application for routine work in quality control laboratories.
